| Literature DB >> 30227838 |
Guanglei Zhao1, Jin Wang1, Jun Xia2, Yibing Wei1, Siqun Wang1, Gangyong Huang1, Feiyan Chen1, Jie Chen1, Jingsheng Shi1, Yuanqing Yang1.
Abstract
BACKGROUND: To explore and evaluate the predictive value of preoperative Neutrophil-lymphocyte ratio (NLR) on the recurrence of pigmented villonodular synovitis (PVNS) of the knee joint treated by arthroscopic surgery combining local radiotherapy.Entities:
Keywords: NLR; Pigmented villonodular synovitis; Recurrence
Mesh:
Year: 2018 PMID: 30227838 PMCID: PMC6145334 DOI: 10.1186/s12891-018-2258-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Macroscopic examination of the synovium before and after the arthroscopic synovectomy. (a-b) hypertrophied synovium with villous transformation and haemosiderin deposition before the surgery, (c-d) images of the knee joint after the synovectomy
Clinical characteristics of all patients (* means statistical difference P < 0.05)
| Total | Recurrent | Non-recurrent | ||
|---|---|---|---|---|
| Patients (n) | 60 | 14 | 46 | – |
| Age (years) | 32.00 (26.25–47.00) | 35.50 (28.75–50.00) | 32.00 (26.00–48.25) | 0.45 |
| Gender (F/M) | 31/29 | 6/8 | 25/21 | 0.45 |
| Body mass index (kg/m2) | 22.81 ± 1.81 | 23.31 ± 1.12 | 22.65 ± 1.95 | 0.12 |
| Knee(L/R) | 34/26 | 5/9 | 29/17 | 0.07 |
| WBC (10^9/L) | 6.57 (5.54–8.21) | 7.01 (5.57–8.38) | 6.57 (5.35–8.28) | 0.51 |
| ESR (mm/h) | 14.00 (11.25–19.00) | 16.50 (10.00–27.00) | 13.50 (11.75–17.25) | 0.208 |
| CRP (mg/L) | 13.30 (6.34–21.25) | 17.31 (10.45–27.55) | 12.51 (6.17–15.86) | 0.04* |
| Neutrophils (10^9/L) | 3.59 (2.92–4.53) | 4.07 (3.22–5.36) | 3.26 (2.52–4.51) | 0.134 |
| Platelets (10^9/L) | 242.00 (189.75–281.25) | 260.50 (235.00–282.25) | 233.50 (180.75–278.50) | 0.21 |
| Lymphocytes (10^9/L) | 1.87 (1.50–2.19) | 1.83 (1.30–2.23) | 1.87 (1.57–2.11) | 0.69 |
| Monocytes (10^9/L) | 0.38 (0.32–0.46) | 0.35 (0.32–0.46) | 0.38 (0.32–0.46) | 0.49 |
| PLR | 125.29 (105.04–152.58) | 127.96 (104.05–233.92) | 124.07 (105.71–148.65) | 0.23 |
| NLR | 1.89 (1.40–2.50) | 2.63 (2.05–2.84) | 1.77 (1.36–2.25) | 0.002* |
| LMR | 4.76 (4.02–5.87) | 4.75 (3.78–5.80) | 4.76 (4.03–5.94) | 0.68 |
Multiple logistic regression analysis of factors associated with relapse of PVNS of the knee joint. OR: odds ratio, 95% CI: 95% confidence intervals
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95% Cl | OR | 95% Cl | |||
| Gender | 1.587 | 0.475–5.307 | 0.453 | 1.217 | 0.176–8.411 | 0.842 |
| Age | 1.017 | 0.975–1.060 | 0.442 | 0.982 | 0.918–1.051 | 0.596 |
| Body mass index | 1.249 | 0.866–1.802 | 0.233 | 1.065 | 0.652–1.741 | 0.800 |
| ESR | 1.063 | 0.983–1.148 | 0.126 | 1.084 | 0.968–1.214 | 0.162 |
| CRP | 1.074 | 1.004–1.149 | 0.038* | 1.113 | 1.004–1.235 | 0.043* |
| Neutrophils | 1.467 | 0.884–2.434 | 0.138 | 1.063 | 0.478–2.363 | 0.823 |
| NLR | 6.595 | 1.877–23.170 | 0.003* | 7.999 | 1.451–44.103 | 0.017* |
*P values represent statistically significant differences
Fig. 2Receiver operating characteristic (ROC) curves for the neutrophil-to-lymphocyte ratio (NLR), Platelet-lymphocyte ratio (PLR), Lymphocyte-monocyte ratio (LMR) erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP)
The knee joint function in recurrent group
| Preoperative | Relapse / final follow up | ||
|---|---|---|---|
| KSS clinical score | 59.13 ± 7.59 (48–73) | 64.88 ± 9.03 (50–77) | 0.218 |
| KSS function score | 54.38 ± 18.20 (15–72) | 60.38 ± 19.32 (20–78) | 0.559 |
| Lyshoml score | 57.38 ± 12.91 (40–72) | 62.38 ± 13.25 (43–76) | 0.486 |
The knee joint function in non-recurrent group (*means statistical difference P < 0.05)
| Preoperative | Final follow up | ||
|---|---|---|---|
| KSS clinical score | 68.12 ± 3.96 | 87.44 ± 5.20 | < 0.001* |
| KSS function score | 70.28 ± 4.88 | 88.92 ± 6.95 | < 0.001* |
| Lyshoml score | 66.96 ± 8.70 | 84.32 ± 9.72 | < 0.001* |